Inhibition of melanoma cell proliferation by targeting Wnt/β-catenin pathway through Sox4 RNA interference

Huahua Cai1, Anhong Ni1, Wen Li1

  • 1Department of Dermatology and Venereology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Insights

Sox4 gene silencing in melanoma cells reduced beta-catenin protein, inhibiting the Wnt/beta-catenin pathway and decreasing cell proliferation. This suggests Sox4 promotes malignant melanoma progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Wnt/β-catenin signaling pathway is crucial in various cancers, including malignant melanoma.
  • Sox4, a transcription factor, has been implicated in cancer progression, but its role in melanoma signaling is not fully understood.

Purpose of the Study:

  • To investigate the effect of Sox4 gene silencing on the Wnt/β-catenin signaling pathway in the human malignant melanoma cell line A375.
  • To determine if Sox4 influences melanoma cell proliferation via this pathway.

Main Methods:

  • Sox4 gene silencing was achieved using small interfering RNA (siRNA) in A375 cells.
  • Real-time PCR and Western blot were used to measure gene and protein expression of Sox4, Wnt3a, β-catenin, and Survivin.
  • MTT assays and β-catenin/TCF transcription reporter assays assessed cell proliferation and pathway activity, respectively.

Main Results:

  • Sox4 siRNA successfully reduced Sox4 expression without affecting Wnt3a levels.
  • Sox4 knockdown led to decreased β-catenin protein levels and significantly inhibited Wnt/β-catenin pathway activity.
  • The expression of Survivin, a target gene, decreased, and melanoma cell proliferation was attenuated.

Conclusions:

  • Sox4 plays a significant role in regulating the Wnt/β-catenin signaling pathway in malignant melanoma cells.
  • Sox4 influences melanoma progression by modulating β-catenin protein levels and downstream signaling, suggesting it as a potential therapeutic target.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...